Abstract:Background: Metagenomic next-generation sequencing (mNGS) demonstrates great promise as a diagnostic tool for determining the cause of pathogenic infections. The standard diagnostic procedures (SDP) include smears and cultures and are typically viewed as less sensitive and more time-consuming when compared to mNGS. There are concerns about the logistics and ease of transition from SDP to mNGS. mNGS lacks standardization of collection processes, databases, and sequencing. Additionally, there is the burden of training clinicians on interpreting mNGS results. background: Metagenomic next-generation sequencing (mNGS) demonstrates great promise as a diagnostic tool for determining the cause of pathogenic infections. The current standard diagnostic procedures (SDP) include smears and cultures and are typically viewed as less sensitive and more time-consuming when compared to mNGS. There are concerns about the logistics and ease of transition from SDP to mNGS. mNGS lacks standardization of collection processes, databases, and sequencing. Additionally, there is the burden of training clinicians on interpreting mNGS results. Objective: Until now, few studies have explored factors that could be used as early adoption candidates to ease the transition between SDP and mNGS. This study evaluated 123 patients who had received both SDP and mNGS and compared several variables across a diagnostic test evaluation. objective: Until now, few studies have explored factors that could be used as early adoption candidates to ease the transition between current diagnostic procedures and mNGS. This study evaluated 123 patients who had received both SDP and mNGS and compared several variables across a diagnostic test evaluation. Methods: The diagnostic test evaluation observed metrics such as sensitivity, specificity, positive and negative likelihood ratios (PLR, NLR), positive and negative predictive values (PPV, NPV), and accuracy. Factors included various sample sources such as bronchoalveolar lavage fluid (BALF), lung tissue, and cerebral spinal fluid (CSF). An additional factor observed was the patient's immune status. Results: Pathogen detection was found to be significantly greater for mNGS for total patients, BALF sample source, CSF sample source, and non-immunocompromised patients (p<0.05). Pathogen detection was found to be insignificant for lung tissue sample sources and immunocompromised patients. Sensitivity, PLR, NLR, PPV, NPV, and accuracy appeared to be higher with mNGS for the total patients, BALF sample source, and non-immunocompromised patients when compared with SDP (p<0.05). result: Disease detection was found to be significantly different (p<0>0.05) for lung tissue sample sources and immunocompromised patients. Sensitivity, PLR, NLR, PPV, NPV, and accuracy appeared to be higher for the total patients, BALF sample source, and non-immunocompromised patients when comparing mNGS and SDP. Conclusion: With higher metrics in sensitivity, specificity, PLR, NLR, PPV, NPV, and accuracy for overall patients, mNGS may prove a better diagnostic tool than SDP. When addressing sample sources, mNGS for BALF-collected samples appeared to have higher scores than SDP for the same metrics. When patients were in a non-immunocompromised state, mNGS also demonstrated greater diagnostic benefits to BALF and overall patients compared to SDP. This study demonstrates that using BALF as a sample source and selecting non-immunocompromised patients may prove beneficial as early adoption factors for mNGS standard protocol. Such a study may pave the road for mNGS as a routine clinical method for determining the exact pathogenic etiology of lung infections.

Large Cohort Study of Respiratory Tract Infection Patients by Breath Analysis: Early Results

Rational Lung Tissue and Animal Models for Rapid Breath Tests to Determine Pneumonia and Pathogens

Breath Analysis for Noninvasively Differentiating Acinetobacter Baumannii Ventilator-Associated Pneumonia from Its Respiratory Tract Colonization of Ventilated Patients

Identifying Volatile Metabolite Signatures for the Diagnosis of Bacterial Respiratory Tract Infection Using Electronic Nose Technology: A Pilot Study.

Utility, feasibility, and socio-demographic considerations in the diagnosis of bacterial RTI's by GC-IMS breath analysis

A Breath-Based In Vitro Diagnostics for Lower Respiratory Tract Infection

Rapid differentiation of cystic fibrosis-related bacteria via reagentless atmospheric pressure photoionisation mass spectrometry

A simple breath test for tuberculosis using ion mobility: A pilot study

Real-time breath analysis towards a healthy human breath profile

Breath Analysis of COVID-19 Patients in a Tertiary UK Hospital by Optical Spectrometry: The E-Nose CoVal Study

Breathomics: may it become an affordable, new tool for early diagnosis of non-small-cell lung cancer? An exploratory study on a cohort of 60 patients

Smelling the Disease: Diagnostic Potential of Breath Analysis

Exhaled Breath Analysis Detects the Clearance of Staphylococcus aureus from the Airways of Children with Cystic Fibrosis

Breath Analysis for Lung Cancer Early Detection-A Clinical Study

Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia

Breathomics - Distinguishing Minimal From Overt Hepatic Encephalopathy by Volatile Organic Compound Detection in Breath: A Pilot Study

A breath-based in vitro diagnostic assay for the detection of lower respiratory tract infections

Antibiotic resistance, bacterial transmission and improved prediction of bacterial infection in patients with antibody deficiency

Breath Analysis as a Potential and Non-Invasive Frontier in Disease Diagnosis: An Overview

Determination of Ideal Factors for Early Adoption and Standardization of Metagenomic Next-Generation Sequencing for Respiratory System Infections

245 Detection of human respiratory pathogens in air and surface samples collected in several workplaces and public spaces